Literature DB >> 26455459

Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms.

Rosario Moratalla1, Amit Khairnar2, Nicola Simola3, Noelia Granado4, Jose Ruben García-Montes4, Pier Francesca Porceddu3, Yousef Tizabi5, Giulia Costa3, Micaela Morelli6.   

Abstract

Amphetamine-related drugs, such as 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine (METH), are popular recreational psychostimulants. Several preclinical studies have demonstrated that, besides having the potential for abuse, amphetamine-related drugs may also elicit neurotoxic and neuroinflammatory effects. The neurotoxic potentials of MDMA and METH to dopaminergic and serotonergic neurons have been clearly demonstrated in both rodents and non-human primates. This review summarizes the species-specific cellular and molecular mechanisms involved in MDMA and METH-mediated neurotoxic and neuroinflammatory effects, along with the most important behavioral changes elicited by these substances in experimental animals and humans. Emphasis is placed on the neuropsychological and neurological consequences associated with the neuronal damage. Moreover, we point out the gap in our knowledge and the need for developing appropriate therapeutic strategies to manage the neurological problems associated with amphetamine-related drug abuse.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3,4-Methylenedioxymethamphetamine; Dopamine; Ecstasy; MDMA; METH; Methamphetamine; Mouse; Neurodegeneration; Neuroinflammation neurotoxicity; Non-human primate; Rat

Mesh:

Substances:

Year:  2015        PMID: 26455459     DOI: 10.1016/j.pneurobio.2015.09.011

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  55 in total

Review 1.  Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.

Authors:  Irina N Krasnova; Zuzana Justinova; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2016-02-12       Impact factor: 4.530

2.  Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity.

Authors:  Giulia Costa; Micaela Morelli; Nicola Simola
Journal:  Neurotox Res       Date:  2018-04-09       Impact factor: 3.911

3.  Diffusion Kurtosis Imaging as a Tool in Neurotoxicology.

Authors:  Brian Hansen
Journal:  Neurotox Res       Date:  2019-08-17       Impact factor: 3.911

Review 4.  Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Authors:  Lee E Dunlap; Anne M Andrews; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-07-12       Impact factor: 4.418

5.  Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity.

Authors:  Aram B Cholanians; Andy V Phan; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2019-07-01       Impact factor: 4.849

6.  Complement Factor H Displays Opposite Expression Patterns Under Two Situations of Methamphetamine Administration: Acute Exposure and Chronic Dependence.

Authors:  Ming Lin; Jiamin Xu; Zhimin Liu; Liang Qin; Xiaodong Wang; Xiaoping Pu
Journal:  Neurosci Bull       Date:  2020-09-07       Impact factor: 5.203

Review 7.  [Methamphetamine : Epidemiology, clinical importance and sequelae of abuse].

Authors:  N Arnaud; R Thomasius
Journal:  Nervenarzt       Date:  2017-09       Impact factor: 1.214

8.  D-Amphetamine Exposure Differentially Disrupts Signaling Across Ontogeny in the Zebrafish.

Authors:  Bradley J Serpa; Jennifer D Bullard; Victoria C Mendiola; Crystal J Smith; Brandon Stewart; Lisa R Ganser
Journal:  Bioelectricity       Date:  2019-06-14

Review 9.  Neurotoxicology of Synthetic Cathinone Analogs.

Authors:  Mariana Angoa-Pérez; John H Anneken; Donald M Kuhn
Journal:  Curr Top Behav Neurosci       Date:  2017

10.  Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine.

Authors:  John H Anneken; Mariana Angoa-Perez; Girish C Sati; David Crich; Donald M Kuhn
Journal:  Neuropharmacology       Date:  2017-08-26       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.